Discover Why Cannabis Outperforms Opioids for Back Pain: Insights from Two Groundbreaking European Studies

Many people wonder if cannabis can help with back pain. Spine surgeon Dr. Richard Price frequently hears this question from his patients. He explored the evidence a few years ago and found that while many people report relief, robust studies are scarce. Chronic pain is a major reason people turn to medical marijuana, but Dr. Price found the high-quality research lacking.

His patients often share stories about how cannabis helps them relax and sleep better. Recently, two significant clinical trials from Europe examined cannabis for low back pain, a leading cause of disability worldwide. The first study, published in Nature Medicine, revealed that a cannabis oil blend with THC and CBD outperformed a placebo. The second trial showed that the same tincture provided better pain relief compared to opioids, with fewer gastrointestinal side effects.

Dr. Price thinks these studies are crucial and may shape future understanding of cannabis in pain management. However, in the U.S., the path to approval for cannabis products is complicated due to regulations. Currently, cannabis is classified as a Schedule 1 drug, which delays large-scale clinical trials.

The German company Vertanical, which funded these studies, aims to market its full-spectrum cannabis oil, VER-01, in Europe soon. However, before it can be available in the U.S., the FDA requires similar research conducted domestically, potentially taking years.

Experts have mixed feelings about cannabis as a treatment option. Dr. Kevin Boehnke from the University of Michigan notes that cannabis was significantly effective in the clinical trials, especially compared to opioids. Patients experienced improved pain management and better sleep without the same risks associated with opioids.

While cannabis offers benefits, it is not a cure-all for chronic pain. Dr. Simon Haroutounian, a pain expert, emphasizes that while the studies are promising, only around a 10% pain reduction can be credited directly to cannabis after considering the placebo effect.

Cannabis is notably safer than opioids, with little risk of addiction or overdose. Dr. Clemens Fischer from Vertanical highlighted that their participants did not develop dependency or withdrawal symptoms. Many felt able to maintain their daily activities without feeling high.

However, some patients may still experience adverse effects. One case involved a woman who suffered a fall and hip injury after her first dose of cannabis, showcasing risks that still exist.

Currently, only one cannabis-derived medication, Epidiolex, has FDA approval, and it lacks THC. Most patients using cannabis products in states where it’s legal express concerns about product quality and consistency. Patient advocacy groups argue that federal approval for cannabis products would provide reassurance and standardization for those seeking relief from chronic pain.

Many believe in the potential of cannabis, but more research is necessary. Dr. Price supports exploring cannabis as an option for pain relief, especially for patients sensitive to opioids. He highlights the challenges in managing pain when conventional options fail.

This conversation about cannabis reflects a broader societal shift. A significant percentage of Americans now reside in states where cannabis is legal, fueling interest in its medical benefits. However, as this topic continues to evolve, patient advocates stress the importance of rigorous research to ensure safe and effective treatment options for those in pain.

For deeper insights, check FDA and cannabis research and consider the evolving landscape of cannabis usage in treating chronic pain.

Source link